Article type
Abstract
Objectives
In the United States and other countries with multiracial/multiethnic populations, profound disparities in health outcomes persist. Despite awareness of the issue, systematic reviewers for health care decision-making and guidelines do not consistently address racial and ethnic health inequities. This special session will help attendees understand why it is critical and how to advance racial health equity in systematic reviews and clinical practice guidelines. Attendees will gain an improved understanding of emerging directions and actionable strategies.
Description
Producers, funders, and end users of systematic reviews came together at a summit focusing on racial health equity in June 2024. The summit was cohosted by the Agency for Healthcare Research and Quality (AHRQ), a Federal Agency of the US Department of Health and Human Services, and the Robert Wood Johnson Foundation and was supported by the Cochrane US Network. It resulted in prioritized next steps, metrics to demonstrate accountability, and the creation of a network that seeks to advance racial health equity and make commitments for the future. This special session builds on the insights of the attendees of the racial health equity summit and additionally draws upon audits of public nominations to AHRQ, evidence reviews produced by AHRQ and other public funders, and guidelines in the ECRI Guidelines Trust (EGT) database (a publicly available repository).
Activities and interaction plans
This session includes presentations and live polling for 55 min, followed by facilitated discussions for 35 min. Speakers will discuss (a) why addressing racial health equity matters; (b) how it has been addressed in past topic nominations, systematic reviews, and guidelines; (c) considerations and exemplars of asking and answering a broader set of questions around health equity; (d) applications of centering racial health equity in systematic reviews; and (e) findings from the June 2024 summit. Speakers will utilize live polling to gather input from session attendees on specific questions during each presentation. After laying groundwork with initial presentations, the facilitator will present vignettes of reviews and pose questions to the audience to prompt interactive discussion for the remaining 35 min. Feedback from audience members will help shape final guidance documents.
In the United States and other countries with multiracial/multiethnic populations, profound disparities in health outcomes persist. Despite awareness of the issue, systematic reviewers for health care decision-making and guidelines do not consistently address racial and ethnic health inequities. This special session will help attendees understand why it is critical and how to advance racial health equity in systematic reviews and clinical practice guidelines. Attendees will gain an improved understanding of emerging directions and actionable strategies.
Description
Producers, funders, and end users of systematic reviews came together at a summit focusing on racial health equity in June 2024. The summit was cohosted by the Agency for Healthcare Research and Quality (AHRQ), a Federal Agency of the US Department of Health and Human Services, and the Robert Wood Johnson Foundation and was supported by the Cochrane US Network. It resulted in prioritized next steps, metrics to demonstrate accountability, and the creation of a network that seeks to advance racial health equity and make commitments for the future. This special session builds on the insights of the attendees of the racial health equity summit and additionally draws upon audits of public nominations to AHRQ, evidence reviews produced by AHRQ and other public funders, and guidelines in the ECRI Guidelines Trust (EGT) database (a publicly available repository).
Activities and interaction plans
This session includes presentations and live polling for 55 min, followed by facilitated discussions for 35 min. Speakers will discuss (a) why addressing racial health equity matters; (b) how it has been addressed in past topic nominations, systematic reviews, and guidelines; (c) considerations and exemplars of asking and answering a broader set of questions around health equity; (d) applications of centering racial health equity in systematic reviews; and (e) findings from the June 2024 summit. Speakers will utilize live polling to gather input from session attendees on specific questions during each presentation. After laying groundwork with initial presentations, the facilitator will present vignettes of reviews and pose questions to the audience to prompt interactive discussion for the remaining 35 min. Feedback from audience members will help shape final guidance documents.